COST-EFFECTIVENESS OF DENOSUMAB IN PREVENTING OSTEOPOROTIC FRACTURES IN POSTMENOPAUSAL WOMEN FROM THE PRIVATE HEALTH CARE SETTING PERSPECTIVE IN BRAZIL

被引：1
|
作者：
Barbosa, E. G. [1 ]
Machado, M. [1 ]
Araujo, G. T. B. D. [2 ]
Etto, H. [2 ]
Fonseca, M. [3 ]
Olimpio, A. [1 ]
机构：
[1] GlaxoSmithKline Ltda, Rio De Janeiro, Brazil
[2] Axia Bio, Sao Paulo, Brazil
[3] Fed Univ Sao Paulo Axia Bio Consulting, Sao Paulo, Brazil
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 07期
关键词：
D O I：
10.1016/j.jval.2012.08.1396
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A446 / A447
页数：2
相关论文
共 50 条
  • [21] A systematic review of models used in cost-effectiveness analyses of preventing osteoporotic fractures
    L. Si
    T. M. Winzenberg
    A. J. Palmer
    [J]. Osteoporosis International, 2014, 25 : 51 - 60
  • [22] A systematic review of models used in cost-effectiveness analyses of preventing osteoporotic fractures
    Si, L.
    Winzenberg, T. M.
    Palmer, A. J.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2014, 25 (01) : 51 - 60
  • [23] Cost Effectiveness of Denosumab for Secondary Prevention of Osteoporotic Fractures Among Postmenopausal Women in China: An Individual-Level Simulation Analysis
    Yawen Jiang
    Shan Jiang
    Limin Li
    Si Shi
    Mincai Li
    Lei Si
    [J]. Applied Health Economics and Health Policy, 2023, 21 : 489 - 499
  • [24] Cost Effectiveness of Denosumab for Secondary Prevention of Osteoporotic Fractures Among Postmenopausal Women in China: An Individual-Level Simulation Analysis
    Jiang, Yawen
    Jiang, Shan
    Li, Limin
    Shi, Si
    Li, Mincai
    Si, Lei
    [J]. APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2023, 21 (03) : 489 - 499
  • [25] Cost-effectiveness of denosumab for high-risk postmenopausal women with osteoporosis in Thailand
    Pongchaiyakul, Chatlert
    Nanagara, Ratanavadee
    Songpatanasilp, Thawee
    Unnanuntana, Aasis
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2020, 23 (07) : 776 - 785
  • [26] Cost-effectiveness analysis of zoledronic acid versus risedronate for the prevention of osteoporotic hip fracture in the private health care system in Brazil
    Araujo, D.
    Bahia, L.
    Souza, C. P. R.
    Benitez, R.
    Fernandes, R. A.
    Bueno, R. L. P.
    Navarro, J.
    Matsui, M.
    [J]. VALUE IN HEALTH, 2008, 11 (03) : A258 - A258
  • [27] COST-EFFECTIVENESS OF PRIMARY PREVENTION FOR OSTEOPOROTIC HIP FRACTURES IN ELDERLY WOMEN
    Comas, M.
    Posso, M.
    Louro, J.
    Espallargues, M.
    Tebe, C.
    Domingo, L.
    Castells, X.
    [J]. VALUE IN HEALTH, 2018, 21 : S295 - S295
  • [28] Cost-effectiveness of teriparatide in the prevention of osteoporotic fractures in Australian men and women
    Lees, M
    Graham-Clarke, P
    Davey, P
    Thiebaud, D
    Price, N
    Grainger, D
    [J]. OSTEOPOROSIS INTERNATIONAL, 2003, 14 : S12 - S13
  • [29] COST-EFFECTIVENESS OF DENOSUMAB IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS (PMO) WOMEN IN MEXICO AT HIGH RISK OF FRACTURES AND INTOLERANT TO ORAL BISPHOSPHONATES
    Arocho, R.
    Rivera Hurtado, R.
    Salinas Escudero, G.
    [J]. VALUE IN HEALTH, 2013, 16 (03) : A225 - A225
  • [30] Cost-Effectiveness of Bazedoxifene Compared with Raloxifene in the Treatment of Postmenopausal Osteoporotic Women.
    Hiligsmann, Mickael
    Ben Sedrine, Wafa
    Reginster, J. -Y.
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S834 - S834
12345